CDAK
Codiak BioSciences, Inc. Common Stock
CDAK
CDAK
Delisted
CDAK was delisted on the 4th of April, 2023.
49 hedge funds and large institutions have $33.6M invested in Codiak BioSciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 17 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
57% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 21
61% less capital invested
Capital invested by funds: $86.5M → $33.6M (-$52.9M)
Holders
49
Holding in Top 10
1
Calls
$31K
Puts
$12K
Top Buyers
| 1 | +$902K | |
| 2 | +$334K | |
| 3 | +$332K | |
| 4 |
Renaissance Technologies
New York
|
+$234K |
| 5 |
E
Ergoteles
New York
|
+$210K |
Top Sellers
| 1 | -$6.15M | |
| 2 | -$2.04M | |
| 3 | -$755K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$635K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$390K |